Mercury Biopharmaceutical Corp (ROCO:6932)
NT$ 16 0.2 (1.27%) Market Cap: 6.62 Bil Enterprise Value: 6.40 Bil PE Ratio: 0 PB Ratio: 20.49 GF Score: 21/100

Mercury Biopharmaceutical Corp (ROCO:6932) Transcripts

    • 1